Clinical Trial Update: Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating everolimus in combination with carboplatin for pretreated metastatic breast cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Everolimus (everolimus)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN